

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 5.94293893 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.68285178 |
| 3 | locomotory exploration behavior (GO:0035641) | 5.67037965 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.14210278 |
| 5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.99698603 |
| 6 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.92789909 |
| 7 | vocalization behavior (GO:0071625) | 4.66011260 |
| 8 | glutamate secretion (GO:0014047) | 4.60253373 |
| 9 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.48408166 |
| 10 | regulation of synapse structural plasticity (GO:0051823) | 4.42271396 |
| 11 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.39763716 |
| 12 | synaptic vesicle exocytosis (GO:0016079) | 4.35815086 |
| 13 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.20586862 |
| 14 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.19921302 |
| 15 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.19324903 |
| 16 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.08096563 |
| 17 | sodium ion export (GO:0071436) | 4.06669009 |
| 18 | exploration behavior (GO:0035640) | 4.05344766 |
| 19 | layer formation in cerebral cortex (GO:0021819) | 4.03674179 |
| 20 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.94097979 |
| 21 | activation of protein kinase A activity (GO:0034199) | 3.91829955 |
| 22 | cell communication by electrical coupling (GO:0010644) | 3.87576221 |
| 23 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.85403601 |
| 24 | regulation of synaptic vesicle transport (GO:1902803) | 3.81711827 |
| 25 | protein localization to synapse (GO:0035418) | 3.80758101 |
| 26 | neurotransmitter secretion (GO:0007269) | 3.79735529 |
| 27 | thymic T cell selection (GO:0045061) | 3.78891514 |
| 28 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.77241880 |
| 29 | positive thymic T cell selection (GO:0045059) | 3.73956291 |
| 30 | dendritic spine morphogenesis (GO:0060997) | 3.71502252 |
| 31 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.64574070 |
| 32 | cellular potassium ion homeostasis (GO:0030007) | 3.61883735 |
| 33 | proline transport (GO:0015824) | 3.55342213 |
| 34 | regulation of ARF protein signal transduction (GO:0032012) | 3.51194023 |
| 35 | long-term memory (GO:0007616) | 3.45183459 |
| 36 | positive T cell selection (GO:0043368) | 3.41881392 |
| 37 | T cell selection (GO:0045058) | 3.40800935 |
| 38 | neuromuscular process controlling balance (GO:0050885) | 3.39860842 |
| 39 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.39038188 |
| 40 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.38819537 |
| 41 | mannose metabolic process (GO:0006013) | 3.37487811 |
| 42 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.36865300 |
| 43 | negative thymic T cell selection (GO:0045060) | 3.36457884 |
| 44 | synaptic transmission, glutamatergic (GO:0035249) | 3.33318884 |
| 45 | negative T cell selection (GO:0043383) | 3.32483356 |
| 46 | signal complex assembly (GO:0007172) | 3.32222357 |
| 47 | gamma-aminobutyric acid transport (GO:0015812) | 3.30780860 |
| 48 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.29281558 |
| 49 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.27303138 |
| 50 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.25846329 |
| 51 | negative regulation of cell killing (GO:0031342) | 3.25778402 |
| 52 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.25778402 |
| 53 | neuronal action potential propagation (GO:0019227) | 3.24920005 |
| 54 | positive regulation of granulocyte differentiation (GO:0030854) | 3.22873784 |
| 55 | positive regulation of membrane potential (GO:0045838) | 3.22173618 |
| 56 | cerebellar granule cell differentiation (GO:0021707) | 3.21946408 |
| 57 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.21796611 |
| 58 | cell communication involved in cardiac conduction (GO:0086065) | 3.21352538 |
| 59 | positive regulation of synapse maturation (GO:0090129) | 3.18623686 |
| 60 | regulation of synaptic plasticity (GO:0048167) | 3.18173659 |
| 61 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.16728660 |
| 62 | membrane depolarization during action potential (GO:0086010) | 3.15831054 |
| 63 | B cell receptor signaling pathway (GO:0050853) | 3.15174217 |
| 64 | positive regulation of CREB transcription factor activity (GO:0032793) | 3.12371798 |
| 65 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.12293589 |
| 66 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.06503201 |
| 67 | regulation of postsynaptic membrane potential (GO:0060078) | 3.06099532 |
| 68 | prepulse inhibition (GO:0060134) | 3.05660392 |
| 69 | cellular sodium ion homeostasis (GO:0006883) | 3.05426207 |
| 70 | glutamate receptor signaling pathway (GO:0007215) | 3.03619787 |
| 71 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.03349346 |
| 72 | neuron-neuron synaptic transmission (GO:0007270) | 2.98602162 |
| 73 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.97281583 |
| 74 | glycine transport (GO:0015816) | 2.95920036 |
| 75 | potassium ion import (GO:0010107) | 2.94783019 |
| 76 | auditory behavior (GO:0031223) | 2.90317428 |
| 77 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.90084859 |
| 78 | dendrite morphogenesis (GO:0048813) | 2.89285307 |
| 79 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.87509058 |
| 80 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.87350632 |
| 81 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.86560264 |
| 82 | alanine transport (GO:0032328) | 2.83391690 |
| 83 | establishment of nucleus localization (GO:0040023) | 2.83320264 |
| 84 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.82999282 |
| 85 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.82923321 |
| 86 | regulation of gamma-delta T cell activation (GO:0046643) | 2.79830594 |
| 87 | neurotransmitter transport (GO:0006836) | 2.79138762 |
| 88 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.78568986 |
| 89 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.78544873 |
| 90 | regulation of neurotransmitter secretion (GO:0046928) | 2.77803700 |
| 91 | neuronal ion channel clustering (GO:0045161) | 2.75911414 |
| 92 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.75278437 |
| 93 | membrane repolarization (GO:0086009) | 2.75096136 |
| 94 | membrane depolarization (GO:0051899) | 2.73952235 |
| 95 | neuromuscular process controlling posture (GO:0050884) | 2.73811035 |
| 96 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.73376585 |
| 97 | Peyers patch development (GO:0048541) | 2.73376585 |
| 98 | positive regulation of neurotransmitter transport (GO:0051590) | 2.73093251 |
| 99 | dendritic spine organization (GO:0097061) | 2.72867785 |
| 100 | regulation of dendritic spine development (GO:0060998) | 2.72263874 |
| 101 | vesicle transport along microtubule (GO:0047496) | 2.71922296 |
| 102 | regulation of neurotransmitter levels (GO:0001505) | 2.71546197 |
| 103 | regulation of ARF GTPase activity (GO:0032312) | 2.69245674 |
| 104 | regulation of Rap GTPase activity (GO:0032317) | 2.68912225 |
| 105 | neuron cell-cell adhesion (GO:0007158) | 2.68386550 |
| 106 | tolerance induction (GO:0002507) | 2.68213134 |
| 107 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.68064813 |
| 108 | positive regulation of dendritic spine development (GO:0060999) | 2.67815432 |
| 109 | activation of JUN kinase activity (GO:0007257) | 2.66746660 |
| 110 | regulation of synapse maturation (GO:0090128) | 2.66701560 |
| 111 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.66562458 |
| 112 | nerve growth factor signaling pathway (GO:0038180) | 2.66044062 |
| 113 | negative regulation of myotube differentiation (GO:0010832) | 2.65801229 |
| 114 | regulation of membrane repolarization (GO:0060306) | 2.65380155 |
| 115 | innervation (GO:0060384) | 2.64377465 |
| 116 | positive regulation of fibroblast migration (GO:0010763) | 2.64253111 |
| 117 | chemosensory behavior (GO:0007635) | 2.63708047 |
| 118 | long-term synaptic potentiation (GO:0060291) | 2.63346171 |
| 119 | response to auditory stimulus (GO:0010996) | 2.63276752 |
| 120 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.62932271 |
| 121 | regulation of ion transmembrane transporter activity (GO:0032412) | 2.60853177 |
| 122 | cerebellar Purkinje cell layer development (GO:0021680) | 2.60597596 |
| 123 | plasma membrane repair (GO:0001778) | 2.58555335 |
| 124 | regulation of neurotransmitter transport (GO:0051588) | 2.57883488 |
| 125 | neuromuscular process (GO:0050905) | 2.57254903 |
| 126 | synaptic vesicle endocytosis (GO:0048488) | 2.57026055 |
| 127 | positive regulation of Rap GTPase activity (GO:0032854) | 2.56730673 |
| 128 | dopamine receptor signaling pathway (GO:0007212) | 2.56634043 |
| 129 | regulation of platelet aggregation (GO:0090330) | 2.54812337 |
| 130 | protein targeting to plasma membrane (GO:0072661) | 2.48635310 |
| 131 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.47478397 |
| 132 | histone H3-K36 demethylation (GO:0070544) | 2.46374251 |
| 133 | megakaryocyte development (GO:0035855) | 2.45089463 |
| 134 | response to laminar fluid shear stress (GO:0034616) | 2.45004144 |
| 135 | adenosine receptor signaling pathway (GO:0001973) | 2.42890825 |
| 136 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.42775386 |
| 137 | regulation of histone H3-K27 methylation (GO:0061085) | 2.41470076 |
| 138 | histone H4 deacetylation (GO:0070933) | 2.41103901 |
| 139 | regulation of granulocyte differentiation (GO:0030852) | 2.37993070 |
| 140 | L-amino acid import (GO:0043092) | 2.37980056 |
| 141 | positive regulation of protein dephosphorylation (GO:0035307) | 2.37974992 |
| 142 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.37339102 |
| 143 | apoptotic process involved in morphogenesis (GO:0060561) | 2.36745490 |
| 144 | histone H3 deacetylation (GO:0070932) | 2.36020079 |
| 145 | cell-substrate adherens junction assembly (GO:0007045) | 2.34553625 |
| 146 | focal adhesion assembly (GO:0048041) | 2.34553625 |
| 147 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.34475641 |
| 148 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.34475641 |
| 149 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.34460560 |
| 150 | cellular response to epinephrine stimulus (GO:0071872) | 2.33670439 |
| 151 | response to interleukin-15 (GO:0070672) | 2.30359595 |
| 152 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.27116170 |
| 153 | protein carboxylation (GO:0018214) | 2.27116170 |
| 154 | response to muramyl dipeptide (GO:0032495) | 2.23911670 |
| 155 | angiogenesis involved in wound healing (GO:0060055) | 2.23047750 |
| 156 | regulation of extracellular matrix disassembly (GO:0010715) | 2.23013925 |
| 157 | regulation of leukocyte degranulation (GO:0043300) | 2.21655821 |
| 158 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.21620772 |
| 159 | regulation of regulated secretory pathway (GO:1903305) | 2.20746900 |
| 160 | amino acid import (GO:0043090) | 2.20638914 |
| 161 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.20505028 |
| 162 | receptor recycling (GO:0001881) | 2.18991928 |
| 163 | adherens junction assembly (GO:0034333) | 2.14730334 |
| 164 | blood coagulation, intrinsic pathway (GO:0007597) | 2.13734570 |
| 165 | negative regulation of Ras protein signal transduction (GO:0046580) | 2.10952459 |
| 166 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.10305428 |
| 167 | myelin maintenance (GO:0043217) | 2.09786855 |
| 168 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.09649015 |
| 169 | leukocyte aggregation (GO:0070486) | 2.08964434 |
| 170 | germinal center formation (GO:0002467) | 2.08232160 |
| 171 | negative regulation of fibrinolysis (GO:0051918) | 2.06366964 |
| 172 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.05673627 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.04655668 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 3.00944019 |
| 3 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.96169948 |
| 4 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.82723257 |
| 5 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.67011217 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.56967902 |
| 7 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.55038062 |
| 8 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.51583443 |
| 9 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.43954710 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.43699797 |
| 11 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.43699797 |
| 12 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.43000978 |
| 13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.34561585 |
| 14 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.33511006 |
| 15 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.29204108 |
| 16 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.28266773 |
| 17 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.17338951 |
| 18 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.07618753 |
| 19 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.06113917 |
| 20 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.04843064 |
| 21 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.03530290 |
| 22 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.02783663 |
| 23 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.02106059 |
| 24 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.97703255 |
| 25 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.94742862 |
| 26 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.94189316 |
| 27 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.93831942 |
| 28 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.91543753 |
| 29 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.87397155 |
| 30 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.82195991 |
| 31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.81621448 |
| 32 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.77673753 |
| 33 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.75088565 |
| 34 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.75031449 |
| 35 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.74801211 |
| 36 | * MAF_26560356_Chip-Seq_TH1_Human | 1.73380943 |
| 37 | P68_20966046_ChIP-Seq_HELA_Human | 1.70832524 |
| 38 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.70287238 |
| 39 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.70067265 |
| 40 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.69679432 |
| 41 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.68954799 |
| 42 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.66137480 |
| 43 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.65966421 |
| 44 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.65427156 |
| 45 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.64028979 |
| 46 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.62496881 |
| 47 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61355595 |
| 48 | MAF_26560356_Chip-Seq_TH2_Human | 1.58191649 |
| 49 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.57862838 |
| 50 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.57736103 |
| 51 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.57057461 |
| 52 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.57050794 |
| 53 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.54580331 |
| 54 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.54269069 |
| 55 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.52888792 |
| 56 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.52592153 |
| 57 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.52200326 |
| 58 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.49248004 |
| 59 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.48907581 |
| 60 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.47573975 |
| 61 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.42685012 |
| 62 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.41885590 |
| 63 | SPI1_23127762_ChIP-Seq_K562_Human | 1.41587150 |
| 64 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.41076541 |
| 65 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.38301081 |
| 66 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.37330471 |
| 67 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.36259046 |
| 68 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.33686958 |
| 69 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.32713655 |
| 70 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.29572448 |
| 71 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.28976864 |
| 72 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.28968345 |
| 73 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.27015074 |
| 74 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.26978886 |
| 75 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.26600813 |
| 76 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.25620563 |
| 77 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.25600275 |
| 78 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.24177428 |
| 79 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.23515854 |
| 80 | * AR_19668381_ChIP-Seq_PC3_Human | 1.22234942 |
| 81 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.19899399 |
| 82 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.18458130 |
| 83 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.15370941 |
| 84 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.15338208 |
| 85 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15122975 |
| 86 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.14689002 |
| 87 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.14665736 |
| 88 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.14099012 |
| 89 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.14078687 |
| 90 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.13156051 |
| 91 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.12384418 |
| 92 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.11340904 |
| 93 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.10421173 |
| 94 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10201687 |
| 95 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.09386480 |
| 96 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.08769662 |
| 97 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.08144514 |
| 98 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.07820306 |
| 99 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07756086 |
| 100 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.07518541 |
| 101 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.07367899 |
| 102 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.07276518 |
| 103 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.07124931 |
| 104 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.06515828 |
| 105 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.04095737 |
| 106 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.04082437 |
| 107 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.03402727 |
| 108 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.02598898 |
| 109 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02581676 |
| 110 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.02376954 |
| 111 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.01873552 |
| 112 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.01314589 |
| 113 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.00911289 |
| 114 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.00871594 |
| 115 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.00777116 |
| 116 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.00683129 |
| 117 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.00462193 |
| 118 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.00107578 |
| 119 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.00008166 |
| 120 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.99127604 |
| 121 | * MYB_26560356_Chip-Seq_TH1_Human | 0.98939614 |
| 122 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.97074406 |
| 123 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.97024046 |
| 124 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.97014587 |
| 125 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.96739450 |
| 126 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.96662866 |
| 127 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96300822 |
| 128 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95389432 |
| 129 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.95380634 |
| 130 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.95142610 |
| 131 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.95136206 |
| 132 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.94654081 |
| 133 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.94110346 |
| 134 | MYB_26560356_Chip-Seq_TH2_Human | 0.93660302 |
| 135 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.93113310 |
| 136 | GATA2_19941826_ChIP-Seq_K562_Human | 0.92981701 |
| 137 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.92611720 |
| 138 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.90915888 |
| 139 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.90462783 |
| 140 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 0.90286656 |
| 141 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.90082919 |
| 142 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.89805523 |
| 143 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.89649020 |
| 144 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.86939979 |
| 145 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.85648518 |
| 146 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.85525007 |
| 147 | STAT3_23295773_ChIP-Seq_U87_Human | 0.85423745 |
| 148 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 0.85299181 |
| 149 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.84545497 |
| 150 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.84302038 |
| 151 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.83571696 |
| 152 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.82607693 |
| 153 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.81921447 |
| 154 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.80780988 |
| 155 | RXR_22108803_ChIP-Seq_LS180_Human | 0.80559388 |
| 156 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.80526749 |
| 157 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.80477749 |
| 158 | GATA1_19941826_ChIP-Seq_K562_Human | 0.79648373 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 7.25356741 |
| 2 | MP0002822_catalepsy | 4.19101425 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.95229649 |
| 4 | MP0004270_analgesia | 3.46259827 |
| 5 | MP0003763_abnormal_thymus_physiology | 3.19119533 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.15244353 |
| 7 | MP0003880_abnormal_central_pattern | 3.07897554 |
| 8 | MP0009745_abnormal_behavioral_response | 3.06665415 |
| 9 | MP0002064_seizures | 2.68898874 |
| 10 | MP0005464_abnormal_platelet_physiology | 2.66495134 |
| 11 | MP0001968_abnormal_touch/_nociception | 2.59661365 |
| 12 | MP0002909_abnormal_adrenal_gland | 2.44868714 |
| 13 | MP0005409_darkened_coat_color | 2.42691595 |
| 14 | MP0002572_abnormal_emotion/affect_behav | 2.39842473 |
| 15 | MP0003172_abnormal_lysosome_physiology | 2.39599289 |
| 16 | MP0009780_abnormal_chondrocyte_physiolo | 2.38879746 |
| 17 | MP0003436_decreased_susceptibility_to | 2.31699446 |
| 18 | MP0004858_abnormal_nervous_system | 2.27569135 |
| 19 | MP0009046_muscle_twitch | 2.24111703 |
| 20 | MP0005423_abnormal_somatic_nervous | 2.23297473 |
| 21 | MP0008961_abnormal_basal_metabolism | 2.20629453 |
| 22 | MP0004381_abnormal_hair_follicle | 2.16141222 |
| 23 | MP0002735_abnormal_chemical_nociception | 2.16118398 |
| 24 | MP0000751_myopathy | 2.09330841 |
| 25 | MP0002272_abnormal_nervous_system | 2.09251130 |
| 26 | MP0002734_abnormal_mechanical_nocicepti | 2.08371823 |
| 27 | MP0001348_abnormal_lacrimal_gland | 2.02662824 |
| 28 | MP0003329_amyloid_beta_deposits | 2.00100256 |
| 29 | MP0001486_abnormal_startle_reflex | 1.99848027 |
| 30 | MP0002837_dystrophic_cardiac_calcinosis | 1.97085931 |
| 31 | MP0008569_lethality_at_weaning | 1.89969325 |
| 32 | MP0001501_abnormal_sleep_pattern | 1.85920010 |
| 33 | MP0002736_abnormal_nociception_after | 1.82806802 |
| 34 | MP0002733_abnormal_thermal_nociception | 1.77247975 |
| 35 | MP0004811_abnormal_neuron_physiology | 1.76667825 |
| 36 | MP0001440_abnormal_grooming_behavior | 1.67566974 |
| 37 | MP0003303_peritoneal_inflammation | 1.66787959 |
| 38 | MP0001970_abnormal_pain_threshold | 1.66717855 |
| 39 | MP0005451_abnormal_body_composition | 1.66093475 |
| 40 | MP0004130_abnormal_muscle_cell | 1.64619459 |
| 41 | MP0001800_abnormal_humoral_immune | 1.63828078 |
| 42 | MP0009840_abnormal_foam_cell | 1.61374107 |
| 43 | MP0000703_abnormal_thymus_morphology | 1.54534605 |
| 44 | MP0003300_gastrointestinal_ulcer | 1.54395923 |
| 45 | MP0004947_skin_inflammation | 1.53668087 |
| 46 | MP0003879_abnormal_hair_cell | 1.52144326 |
| 47 | MP0002398_abnormal_bone_marrow | 1.50567912 |
| 48 | MP0001986_abnormal_taste_sensitivity | 1.47930103 |
| 49 | MP0000685_abnormal_immune_system | 1.47903132 |
| 50 | MP0005387_immune_system_phenotype | 1.45589511 |
| 51 | MP0001790_abnormal_immune_system | 1.45589511 |
| 52 | MP0004924_abnormal_behavior | 1.44826128 |
| 53 | MP0005386_behavior/neurological_phenoty | 1.44826128 |
| 54 | MP0008260_abnormal_autophagy | 1.43457847 |
| 55 | MP0001851_eye_inflammation | 1.42793881 |
| 56 | MP0004215_abnormal_myocardial_fiber | 1.42736117 |
| 57 | MP0005000_abnormal_immune_tolerance | 1.42012824 |
| 58 | MP0003633_abnormal_nervous_system | 1.41399651 |
| 59 | MP0002067_abnormal_sensory_capabilities | 1.41113525 |
| 60 | MP0002138_abnormal_hepatobiliary_system | 1.39228754 |
| 61 | MP0000465_gastrointestinal_hemorrhage | 1.37258311 |
| 62 | MP0003191_abnormal_cellular_cholesterol | 1.37016137 |
| 63 | MP0002557_abnormal_social/conspecific_i | 1.36258126 |
| 64 | MP0005670_abnormal_white_adipose | 1.35716521 |
| 65 | MP0003075_altered_response_to | 1.35651878 |
| 66 | MP0003091_abnormal_cell_migration | 1.35244732 |
| 67 | MP0004085_abnormal_heartbeat | 1.33769245 |
| 68 | MP0002396_abnormal_hematopoietic_system | 1.32920703 |
| 69 | MP0000955_abnormal_spinal_cord | 1.32505870 |
| 70 | MP0002184_abnormal_innervation | 1.31110291 |
| 71 | MP0009278_abnormal_bone_marrow | 1.29428860 |
| 72 | MP0005076_abnormal_cell_differentiation | 1.29198822 |
| 73 | MP0005666_abnormal_adipose_tissue | 1.29139606 |
| 74 | MP0004510_myositis | 1.28092034 |
| 75 | MP0004084_abnormal_cardiac_muscle | 1.26501615 |
| 76 | MP0003724_increased_susceptibility_to | 1.26082280 |
| 77 | MP0002420_abnormal_adaptive_immunity | 1.25697790 |
| 78 | MP0001873_stomach_inflammation | 1.25313574 |
| 79 | MP0002723_abnormal_immune_serum | 1.23082513 |
| 80 | MP0003283_abnormal_digestive_organ | 1.22619495 |
| 81 | MP0001819_abnormal_immune_cell | 1.22334193 |
| 82 | MP0008874_decreased_physiological_sensi | 1.22241593 |
| 83 | MP0003646_muscle_fatigue | 1.21697951 |
| 84 | MP0004036_abnormal_muscle_relaxation | 1.20789280 |
| 85 | MP0003566_abnormal_cell_adhesion | 1.18745777 |
| 86 | MP0002066_abnormal_motor_capabilities/c | 1.18553399 |
| 87 | MP0005058_abnormal_lysosome_morphology | 1.18357535 |
| 88 | MP0005167_abnormal_blood-brain_barrier | 1.18211634 |
| 89 | MP0000716_abnormal_immune_system | 1.17149729 |
| 90 | MP0009333_abnormal_splenocyte_physiolog | 1.16984625 |
| 91 | MP0002933_joint_inflammation | 1.16803693 |
| 92 | MP0003183_abnormal_peptide_metabolism | 1.15556323 |
| 93 | MP0002722_abnormal_immune_system | 1.14443594 |
| 94 | MP0004885_abnormal_endolymph | 1.13011147 |
| 95 | MP0000013_abnormal_adipose_tissue | 1.12696374 |
| 96 | MP0004185_abnormal_adipocyte_glucose | 1.12369859 |
| 97 | MP0002882_abnormal_neuron_morphology | 1.10689021 |
| 98 | MP0003137_abnormal_impulse_conducting | 1.10321974 |
| 99 | MP0003279_aneurysm | 1.09610822 |
| 100 | MP0005646_abnormal_pituitary_gland | 1.09344341 |
| 101 | MP0005360_urolithiasis | 1.08403468 |
| 102 | MP0003631_nervous_system_phenotype | 1.06491224 |
| 103 | MP0001835_abnormal_antigen_presentation | 1.06262347 |
| 104 | MP0005535_abnormal_body_temperature | 1.05553657 |
| 105 | MP0000778_abnormal_nervous_system | 1.05453740 |
| 106 | MP0002089_abnormal_postnatal_growth/wei | 1.04865872 |
| 107 | MP0002405_respiratory_system_inflammati | 1.04141585 |
| 108 | MP0010155_abnormal_intestine_physiology | 1.03661610 |
| 109 | MP0001849_ear_inflammation | 1.02953922 |
| 110 | MP0004233_abnormal_muscle_weight | 1.02502185 |
| 111 | MP0000689_abnormal_spleen_morphology | 1.01769918 |
| 112 | MP0002452_abnormal_antigen_presenting | 1.00462604 |
| 113 | MP0010234_abnormal_vibrissa_follicle | 1.00002603 |
| 114 | MP0004145_abnormal_muscle_electrophysio | 0.98775265 |
| 115 | MP0001502_abnormal_circadian_rhythm | 0.97329143 |
| 116 | MP0000604_amyloidosis | 0.97306675 |
| 117 | MP0003787_abnormal_imprinting | 0.97303277 |
| 118 | MP0008872_abnormal_physiological_respon | 0.96632662 |
| 119 | MP0002429_abnormal_blood_cell | 0.94595954 |
| 120 | MP0004087_abnormal_muscle_fiber | 0.93329539 |
| 121 | MP0002069_abnormal_eating/drinking_beha | 0.92756294 |
| 122 | MP0000678_abnormal_parathyroid_gland | 0.92200821 |
| 123 | MP0005025_abnormal_response_to | 0.91120850 |
| 124 | MP0008004_abnormal_stomach_pH | 0.90812654 |
| 125 | MP0000747_muscle_weakness | 0.89076617 |
| 126 | MP0003866_abnormal_defecation | 0.87729094 |
| 127 | MP0001765_abnormal_ion_homeostasis | 0.86940945 |
| 128 | MP0005620_abnormal_muscle_contractility | 0.86854677 |
| 129 | MP0009115_abnormal_fat_cell | 0.86687992 |
| 130 | MP0005671_abnormal_response_to | 0.86524244 |
| 131 | MP0000249_abnormal_blood_vessel | 0.85572141 |
| 132 | MP0005330_cardiomyopathy | 0.85380058 |
| 133 | MP0001177_atelectasis | 0.84789631 |
| 134 | MP0002152_abnormal_brain_morphology | 0.84282057 |
| 135 | MP0004484_altered_response_of | 0.83528646 |
| 136 | MP0005310_abnormal_salivary_gland | 0.83086348 |
| 137 | MP0002269_muscular_atrophy | 0.81328773 |
| 138 | MP0000749_muscle_degeneration | 0.80570879 |
| 139 | MP0002419_abnormal_innate_immunity | 0.79874479 |
| 140 | MP0002090_abnormal_vision | 0.79008026 |
| 141 | MP0003045_fibrosis | 0.78100367 |
| 142 | MP0005085_abnormal_gallbladder_physiolo | 0.77898647 |
| 143 | MP0000569_abnormal_digit_pigmentation | 0.76812627 |
| 144 | MP0002234_abnormal_pharynx_morphology | 0.76100357 |
| 145 | MP0005187_abnormal_penis_morphology | 0.75961239 |
| 146 | MP0002972_abnormal_cardiac_muscle | 0.75715865 |
| 147 | MP0001984_abnormal_olfaction | 0.75690396 |
| 148 | MP0003690_abnormal_glial_cell | 0.74849309 |
| 149 | MP0000003_abnormal_adipose_tissue | 0.71938000 |
| 150 | MP0010368_abnormal_lymphatic_system | 0.71088951 |
| 151 | MP0010329_abnormal_lipoprotein_level | 0.69658083 |
| 152 | MP0002229_neurodegeneration | 0.69551050 |
| 153 | MP0006138_congestive_heart_failure | 0.69233875 |
| 154 | MP0005623_abnormal_meninges_morphology | 0.68571946 |
| 155 | MP0008775_abnormal_heart_ventricle | 0.68208122 |
| 156 | MP0002078_abnormal_glucose_homeostasis | 0.65249562 |
| 157 | MP0003705_abnormal_hypodermis_morpholog | 0.64920793 |
| 158 | MP0006276_abnormal_autonomic_nervous | 0.61402386 |
| 159 | MP0001544_abnormal_cardiovascular_syste | 0.59988042 |
| 160 | MP0005385_cardiovascular_system_phenoty | 0.59988042 |
| 161 | MP0000759_abnormal_skeletal_muscle | 0.59987525 |
| 162 | MP0005365_abnormal_bile_salt | 0.59585899 |
| 163 | MP0005166_decreased_susceptibility_to | 0.59409947 |
| 164 | MP0005375_adipose_tissue_phenotype | 0.59217973 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 6.61814092 |
| 2 | Focal motor seizures (HP:0011153) | 5.31494320 |
| 3 | Focal seizures (HP:0007359) | 4.60067873 |
| 4 | Visual hallucinations (HP:0002367) | 4.25140155 |
| 5 | Prolonged bleeding time (HP:0003010) | 4.17878146 |
| 6 | Abnormality of the lower motor neuron (HP:0002366) | 3.89488557 |
| 7 | Menorrhagia (HP:0000132) | 3.80916869 |
| 8 | Action tremor (HP:0002345) | 3.71525896 |
| 9 | Abnormality of binocular vision (HP:0011514) | 3.69526115 |
| 10 | Diplopia (HP:0000651) | 3.69526115 |
| 11 | Epistaxis (HP:0000421) | 3.42691945 |
| 12 | Ventricular fibrillation (HP:0001663) | 3.42012535 |
| 13 | Bundle branch block (HP:0011710) | 3.33350944 |
| 14 | Poor eye contact (HP:0000817) | 3.28227018 |
| 15 | Dysmetric saccades (HP:0000641) | 3.27070727 |
| 16 | Impaired social interactions (HP:0000735) | 3.22936911 |
| 17 | Abnormal social behavior (HP:0012433) | 3.22936911 |
| 18 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.21684866 |
| 19 | Epileptic encephalopathy (HP:0200134) | 3.19697292 |
| 20 | Depression (HP:0000716) | 3.19343492 |
| 21 | Ankle clonus (HP:0011448) | 3.17421168 |
| 22 | Hyperlipoproteinemia (HP:0010980) | 3.14676379 |
| 23 | Abnormality of the fingertips (HP:0001211) | 3.11286256 |
| 24 | Deep venous thrombosis (HP:0002625) | 3.09260924 |
| 25 | Purpura (HP:0000979) | 3.08712353 |
| 26 | Sudden death (HP:0001699) | 3.07587425 |
| 27 | Supranuclear gaze palsy (HP:0000605) | 3.05215834 |
| 28 | Joint hemorrhage (HP:0005261) | 3.03480063 |
| 29 | Abnormal platelet volume (HP:0011876) | 3.02754415 |
| 30 | Progressive cerebellar ataxia (HP:0002073) | 2.98270922 |
| 31 | Papilledema (HP:0001085) | 2.95765452 |
| 32 | Annular pancreas (HP:0001734) | 2.95097741 |
| 33 | Generalized tonic-clonic seizures (HP:0002069) | 2.94272481 |
| 34 | Febrile seizures (HP:0002373) | 2.88997788 |
| 35 | Torticollis (HP:0000473) | 2.88964638 |
| 36 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.86827343 |
| 37 | Postural instability (HP:0002172) | 2.86440355 |
| 38 | Broad face (HP:0000283) | 2.85885508 |
| 39 | Increased mean platelet volume (HP:0011877) | 2.83681062 |
| 40 | Hemorrhage of the eye (HP:0011885) | 2.81248667 |
| 41 | Absence seizures (HP:0002121) | 2.80747369 |
| 42 | Urinary urgency (HP:0000012) | 2.77560867 |
| 43 | Atonic seizures (HP:0010819) | 2.74770613 |
| 44 | Hemiplegia (HP:0002301) | 2.74134013 |
| 45 | Dysdiadochokinesis (HP:0002075) | 2.73848707 |
| 46 | Insomnia (HP:0100785) | 2.68963141 |
| 47 | Anxiety (HP:0000739) | 2.67264043 |
| 48 | Gingival bleeding (HP:0000225) | 2.61456760 |
| 49 | Focal dystonia (HP:0004373) | 2.57915203 |
| 50 | Cerebral aneurysm (HP:0004944) | 2.55483304 |
| 51 | Pointed chin (HP:0000307) | 2.55047245 |
| 52 | Dysmetria (HP:0001310) | 2.54522996 |
| 53 | Dialeptic seizures (HP:0011146) | 2.53051756 |
| 54 | Exercise-induced myalgia (HP:0003738) | 2.52498856 |
| 55 | Panhypogammaglobulinemia (HP:0003139) | 2.50303063 |
| 56 | Genetic anticipation (HP:0003743) | 2.49115710 |
| 57 | Resting tremor (HP:0002322) | 2.47924373 |
| 58 | Eczematoid dermatitis (HP:0000976) | 2.45341333 |
| 59 | Agammaglobulinemia (HP:0004432) | 2.45103211 |
| 60 | Prolonged QT interval (HP:0001657) | 2.45040311 |
| 61 | Gaze-evoked nystagmus (HP:0000640) | 2.41173748 |
| 62 | Colitis (HP:0002583) | 2.40258125 |
| 63 | Cellulitis (HP:0100658) | 2.40109290 |
| 64 | Truncal ataxia (HP:0002078) | 2.39152365 |
| 65 | Spontaneous hematomas (HP:0007420) | 2.38504310 |
| 66 | Impaired smooth pursuit (HP:0007772) | 2.38402238 |
| 67 | Craniofacial dystonia (HP:0012179) | 2.35750914 |
| 68 | Abnormal EKG (HP:0003115) | 2.35710833 |
| 69 | Broad-based gait (HP:0002136) | 2.35706837 |
| 70 | Heart block (HP:0012722) | 2.35468590 |
| 71 | Atrioventricular block (HP:0001678) | 2.35307591 |
| 72 | Papilloma (HP:0012740) | 2.30072416 |
| 73 | Verrucae (HP:0200043) | 2.30072416 |
| 74 | Hyperacusis (HP:0010780) | 2.29360533 |
| 75 | Lower limb amyotrophy (HP:0007210) | 2.28390566 |
| 76 | Primary atrial arrhythmia (HP:0001692) | 2.25740088 |
| 77 | Stereotypic behavior (HP:0000733) | 2.25032413 |
| 78 | Impaired vibratory sensation (HP:0002495) | 2.24741523 |
| 79 | Spastic gait (HP:0002064) | 2.24356022 |
| 80 | Syncope (HP:0001279) | 2.22097445 |
| 81 | Gastrointestinal inflammation (HP:0004386) | 2.22060495 |
| 82 | Atrial fibrillation (HP:0005110) | 2.21365182 |
| 83 | Bradykinesia (HP:0002067) | 2.19867281 |
| 84 | Cerebral inclusion bodies (HP:0100314) | 2.19141537 |
| 85 | Amblyopia (HP:0000646) | 2.19121915 |
| 86 | Status epilepticus (HP:0002133) | 2.18394579 |
| 87 | Megalencephaly (HP:0001355) | 2.16086443 |
| 88 | Rapidly progressive (HP:0003678) | 2.15810122 |
| 89 | Abnormal atrioventricular conduction (HP:0005150) | 2.14895491 |
| 90 | Insidious onset (HP:0003587) | 2.14116519 |
| 91 | Termporal pattern (HP:0011008) | 2.14116519 |
| 92 | Intention tremor (HP:0002080) | 2.12825375 |
| 93 | Difficulty running (HP:0009046) | 2.12137729 |
| 94 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.12099354 |
| 95 | Slow saccadic eye movements (HP:0000514) | 2.11147914 |
| 96 | Abnormal eating behavior (HP:0100738) | 2.10620738 |
| 97 | Macroorchidism (HP:0000053) | 2.09619760 |
| 98 | Distal lower limb amyotrophy (HP:0008944) | 2.09531865 |
| 99 | Supraventricular tachycardia (HP:0004755) | 2.09506960 |
| 100 | Abnormal platelet function (HP:0011869) | 2.07964808 |
| 101 | Impaired platelet aggregation (HP:0003540) | 2.07964808 |
| 102 | Supraventricular arrhythmia (HP:0005115) | 2.07441211 |
| 103 | Ventricular arrhythmia (HP:0004308) | 2.05399638 |
| 104 | Obstructive sleep apnea (HP:0002870) | 2.05387580 |
| 105 | Onion bulb formation (HP:0003383) | 2.03420598 |
| 106 | Increased IgE level (HP:0003212) | 2.02029463 |
| 107 | Inflammation of the large intestine (HP:0002037) | 2.01542205 |
| 108 | Meningitis (HP:0001287) | 1.99551344 |
| 109 | Abnormality of the common coagulation pathway (HP:0010990) | 1.96898919 |
| 110 | Gastrointestinal stroma tumor (HP:0100723) | 1.96816233 |
| 111 | Upper limb amyotrophy (HP:0009129) | 1.96784946 |
| 112 | Distal upper limb amyotrophy (HP:0007149) | 1.96784946 |
| 113 | Epileptiform EEG discharges (HP:0011182) | 1.96318472 |
| 114 | Ankyloglossia (HP:0010296) | 1.95771300 |
| 115 | EEG with generalized epileptiform discharges (HP:0011198) | 1.95607926 |
| 116 | Neoplasm of the heart (HP:0100544) | 1.95466733 |
| 117 | Lower limb muscle weakness (HP:0007340) | 1.95434912 |
| 118 | Hypsarrhythmia (HP:0002521) | 1.94708099 |
| 119 | Petechiae (HP:0000967) | 1.94558872 |
| 120 | Abnormality of the columella (HP:0009929) | 1.94343794 |
| 121 | Elfin facies (HP:0004428) | 1.94261433 |
| 122 | Xanthomatosis (HP:0000991) | 1.93603526 |
| 123 | Scanning speech (HP:0002168) | 1.93004351 |
| 124 | Hemiparesis (HP:0001269) | 1.92246256 |
| 125 | Hypercortisolism (HP:0001578) | 1.91920244 |
| 126 | Mutism (HP:0002300) | 1.91783678 |
| 127 | Achilles tendon contracture (HP:0001771) | 1.91760804 |
| 128 | Hyporeflexia of lower limbs (HP:0002600) | 1.91009152 |
| 129 | Abnormality of the Achilles tendon (HP:0005109) | 1.89207365 |
| 130 | Neurofibrillary tangles (HP:0002185) | 1.88555262 |
| 131 | Emphysema (HP:0002097) | 1.87986662 |
| 132 | Myotonia (HP:0002486) | 1.84832757 |
| 133 | Hyperventilation (HP:0002883) | 1.84652387 |
| 134 | Persistence of primary teeth (HP:0006335) | 1.84146975 |
| 135 | Clonus (HP:0002169) | 1.83286314 |
| 136 | Spinal canal stenosis (HP:0003416) | 1.82511978 |
| 137 | Dislocated radial head (HP:0003083) | 1.81686570 |
| 138 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.81482472 |
| 139 | Abnormality of pain sensation (HP:0010832) | 1.80856229 |
| 140 | Impaired pain sensation (HP:0007328) | 1.80856229 |
| 141 | Lower limb asymmetry (HP:0100559) | 1.80676270 |
| 142 | Increased variability in muscle fiber diameter (HP:0003557) | 1.80236650 |
| 143 | Neuronal loss in central nervous system (HP:0002529) | 1.79273050 |
| 144 | Gastrointestinal infarctions (HP:0005244) | 1.77944345 |
| 145 | Dysostosis multiplex (HP:0000943) | 1.77480398 |
| 146 | Polygenic inheritance (HP:0010982) | 1.77238677 |
| 147 | Pustule (HP:0200039) | 1.75726240 |
| 148 | Easy fatigability (HP:0003388) | 1.75315031 |
| 149 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.73088806 |
| 150 | Mucopolysacchariduria (HP:0008155) | 1.72564238 |
| 151 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.72564238 |
| 152 | Complement deficiency (HP:0004431) | 1.72526282 |
| 153 | Hypoplasia of the thymus (HP:0000778) | 1.71970223 |
| 154 | Bowel incontinence (HP:0002607) | 1.71216964 |
| 155 | Prolonged partial thromboplastin time (HP:0003645) | 1.69588238 |
| 156 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.68479170 |
| 157 | Pulmonary embolism (HP:0002204) | 1.67601264 |
| 158 | Chest pain (HP:0100749) | 1.67572843 |
| 159 | Recurrent fungal infections (HP:0002841) | 1.66308281 |
| 160 | Truncus arteriosus (HP:0001660) | 1.66301459 |
| 161 | Thin bony cortex (HP:0002753) | 1.66255568 |
| 162 | Severe combined immunodeficiency (HP:0004430) | 1.65540052 |
| 163 | Growth hormone excess (HP:0000845) | 1.65416547 |
| 164 | Supernumerary nipples (HP:0002558) | 1.64125534 |
| 165 | Aneurysm (HP:0002617) | 1.63678303 |
| 166 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.61662305 |
| 167 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.61662305 |
| 168 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.61662305 |
| 169 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.60993383 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.10953996 |
| 2 | NTRK3 | 3.85125638 |
| 3 | MAP3K9 | 3.68438940 |
| 4 | PRKD3 | 3.06454782 |
| 5 | DAPK2 | 2.83194533 |
| 6 | MAP4K1 | 2.77915813 |
| 7 | ERN1 | 2.75732322 |
| 8 | KSR2 | 2.61127638 |
| 9 | PAK6 | 2.27341796 |
| 10 | TRIB3 | 2.26706809 |
| 11 | MINK1 | 2.16445967 |
| 12 | MARK1 | 2.10810180 |
| 13 | CAMKK1 | 2.07996179 |
| 14 | CDK12 | 2.05278854 |
| 15 | MAP3K4 | 2.04604665 |
| 16 | TAOK1 | 1.84153773 |
| 17 | SMG1 | 1.83682563 |
| 18 | NTRK2 | 1.81130160 |
| 19 | NTRK1 | 1.75932366 |
| 20 | SIK2 | 1.68820297 |
| 21 | PKN2 | 1.59941702 |
| 22 | SIK3 | 1.57092453 |
| 23 | GRK6 | 1.56171979 |
| 24 | LMTK2 | 1.55838838 |
| 25 | TYRO3 | 1.54083785 |
| 26 | STK38 | 1.53633865 |
| 27 | FGFR4 | 1.50617239 |
| 28 | MAP2K4 | 1.47318379 |
| 29 | ZAP70 | 1.45755654 |
| 30 | PRKCH | 1.44273263 |
| 31 | RIPK1 | 1.43374628 |
| 32 | KSR1 | 1.41458746 |
| 33 | PHKG1 | 1.41388606 |
| 34 | PHKG2 | 1.41388606 |
| 35 | MAP3K2 | 1.38719930 |
| 36 | CDK5 | 1.37484177 |
| 37 | MAP3K7 | 1.35026278 |
| 38 | DAPK1 | 1.34881190 |
| 39 | MAPK11 | 1.31169177 |
| 40 | RET | 1.25955758 |
| 41 | MAP3K13 | 1.23151637 |
| 42 | MARK2 | 1.15942055 |
| 43 | CAMK1 | 1.14538005 |
| 44 | MAP2K3 | 1.14463738 |
| 45 | BTK | 1.13510131 |
| 46 | MAP2K7 | 1.10935325 |
| 47 | ALK | 1.10383707 |
| 48 | FES | 1.08578959 |
| 49 | PRPF4B | 1.07416652 |
| 50 | SGK3 | 1.05185558 |
| 51 | DMPK | 1.05056764 |
| 52 | HIPK2 | 1.04235597 |
| 53 | SYK | 1.00667748 |
| 54 | LATS2 | 0.98906727 |
| 55 | BLK | 0.98611412 |
| 56 | MAP3K1 | 0.97825959 |
| 57 | CAMK1G | 0.96125390 |
| 58 | JAK1 | 0.94788182 |
| 59 | PDGFRA | 0.94592654 |
| 60 | UHMK1 | 0.92819419 |
| 61 | NLK | 0.92321167 |
| 62 | PDK1 | 0.91265236 |
| 63 | PINK1 | 0.91098723 |
| 64 | HCK | 0.90884514 |
| 65 | STK11 | 0.90562487 |
| 66 | PTK2B | 0.90495154 |
| 67 | PAK3 | 0.88656946 |
| 68 | PRKCG | 0.87016231 |
| 69 | GRK5 | 0.86230793 |
| 70 | FGFR3 | 0.85208645 |
| 71 | ICK | 0.83493409 |
| 72 | RIPK4 | 0.83314058 |
| 73 | EPHB1 | 0.82752583 |
| 74 | PDPK1 | 0.82682505 |
| 75 | NEK1 | 0.81148442 |
| 76 | TYK2 | 0.80520323 |
| 77 | CAMK4 | 0.78908451 |
| 78 | SGK2 | 0.78407728 |
| 79 | BMPR2 | 0.77770184 |
| 80 | CDC42BPA | 0.77555869 |
| 81 | ITK | 0.77184576 |
| 82 | RAF1 | 0.76193589 |
| 83 | MAPK7 | 0.75461529 |
| 84 | TXK | 0.75452092 |
| 85 | SGK223 | 0.75094476 |
| 86 | SGK494 | 0.75094476 |
| 87 | ARAF | 0.72029732 |
| 88 | EEF2K | 0.66498037 |
| 89 | FGFR2 | 0.66080790 |
| 90 | CAMKK2 | 0.64453659 |
| 91 | TNK2 | 0.64444447 |
| 92 | PRKD2 | 0.64297128 |
| 93 | IRAK2 | 0.61943800 |
| 94 | SGK1 | 0.61908365 |
| 95 | CAMK2A | 0.60709434 |
| 96 | MTOR | 0.60690627 |
| 97 | CDK15 | 0.60000424 |
| 98 | MAP2K2 | 0.59865185 |
| 99 | CDK18 | 0.58072297 |
| 100 | SIK1 | 0.57335777 |
| 101 | MAP3K11 | 0.57103828 |
| 102 | CDK4 | 0.56322623 |
| 103 | RPS6KA3 | 0.56270429 |
| 104 | MAPK12 | 0.54243580 |
| 105 | MAPK13 | 0.53391098 |
| 106 | LCK | 0.52867957 |
| 107 | PRKD1 | 0.52371312 |
| 108 | CDK14 | 0.52359980 |
| 109 | TNIK | 0.51747779 |
| 110 | CSK | 0.51629551 |
| 111 | CDK11A | 0.50981354 |
| 112 | MAPK4 | 0.50287595 |
| 113 | MAP3K3 | 0.50112179 |
| 114 | MAP3K10 | 0.49973428 |
| 115 | PRKCZ | 0.48424236 |
| 116 | RPS6KA2 | 0.48369837 |
| 117 | MELK | 0.47277472 |
| 118 | FYN | 0.45862951 |
| 119 | MAP2K1 | 0.45763313 |
| 120 | DAPK3 | 0.45576030 |
| 121 | TTN | 0.44610823 |
| 122 | MAP3K6 | 0.43932437 |
| 123 | SCYL2 | 0.43479090 |
| 124 | PDGFRB | 0.41916815 |
| 125 | NEK6 | 0.41533940 |
| 126 | MARK3 | 0.41185502 |
| 127 | CAMK1D | 0.40239217 |
| 128 | MAPK10 | 0.39695175 |
| 129 | PTK6 | 0.38821236 |
| 130 | CSF1R | 0.38112558 |
| 131 | BMX | 0.37722845 |
| 132 | PRKAA1 | 0.37035793 |
| 133 | JAK3 | 0.36906601 |
| 134 | WNK1 | 0.36584010 |
| 135 | JAK2 | 0.35805889 |
| 136 | FER | 0.33780861 |
| 137 | PRKACG | 0.33388378 |
| 138 | PDK4 | 0.32710553 |
| 139 | PDK3 | 0.32710553 |
| 140 | MAPK8 | 0.32446268 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.50332936 |
| 2 | Olfactory transduction_Homo sapiens_hsa04740 | 2.45948972 |
| 3 | Circadian entrainment_Homo sapiens_hsa04713 | 2.33869744 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.33338935 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.29695138 |
| 6 | Nicotine addiction_Homo sapiens_hsa05033 | 2.20414512 |
| 7 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.11131424 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.06226873 |
| 9 | GABAergic synapse_Homo sapiens_hsa04727 | 2.04784626 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.99858579 |
| 11 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.98260704 |
| 12 | Insulin secretion_Homo sapiens_hsa04911 | 1.96028623 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.95997722 |
| 14 | Morphine addiction_Homo sapiens_hsa05032 | 1.92760025 |
| 15 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.89568048 |
| 16 | Salivary secretion_Homo sapiens_hsa04970 | 1.85461973 |
| 17 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.82447599 |
| 18 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.75293690 |
| 19 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.75136616 |
| 20 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.75120786 |
| 21 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.68398839 |
| 22 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.58722473 |
| 23 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.56075765 |
| 24 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.55577253 |
| 25 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.55112860 |
| 26 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.54267059 |
| 27 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.49924495 |
| 28 | Renin secretion_Homo sapiens_hsa04924 | 1.47546152 |
| 29 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.43188615 |
| 30 | Cocaine addiction_Homo sapiens_hsa05030 | 1.41848656 |
| 31 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.39622392 |
| 32 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.38118514 |
| 33 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.32935715 |
| 34 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.31913534 |
| 35 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.26308253 |
| 36 | Glioma_Homo sapiens_hsa05214 | 1.25840702 |
| 37 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.25220164 |
| 38 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.25210550 |
| 39 | Taste transduction_Homo sapiens_hsa04742 | 1.16758604 |
| 40 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.16280043 |
| 41 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.16185310 |
| 42 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.16172206 |
| 43 | Gap junction_Homo sapiens_hsa04540 | 1.15551604 |
| 44 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.14541470 |
| 45 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.12252160 |
| 46 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.11304461 |
| 47 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.10856411 |
| 48 | Long-term depression_Homo sapiens_hsa04730 | 1.10606502 |
| 49 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.10448954 |
| 50 | Bile secretion_Homo sapiens_hsa04976 | 1.10349990 |
| 51 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.04535607 |
| 52 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.98620922 |
| 53 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.97513164 |
| 54 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.96585053 |
| 55 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.95617220 |
| 56 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.94916506 |
| 57 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.92970719 |
| 58 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.92392213 |
| 59 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.91673145 |
| 60 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.90236367 |
| 61 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.90102869 |
| 62 | Melanogenesis_Homo sapiens_hsa04916 | 0.89903086 |
| 63 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.89734508 |
| 64 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.88334567 |
| 65 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.87783401 |
| 66 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.86872070 |
| 67 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.81747433 |
| 68 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.81024873 |
| 69 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.80168634 |
| 70 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.80110461 |
| 71 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.79037146 |
| 72 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.78556102 |
| 73 | Other glycan degradation_Homo sapiens_hsa00511 | 0.78481108 |
| 74 | Axon guidance_Homo sapiens_hsa04360 | 0.77455840 |
| 75 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.76991027 |
| 76 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.76375156 |
| 77 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.75229343 |
| 78 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.74671945 |
| 79 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.74544609 |
| 80 | Colorectal cancer_Homo sapiens_hsa05210 | 0.74015813 |
| 81 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.73575978 |
| 82 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.72629061 |
| 83 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.72463376 |
| 84 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.72326490 |
| 85 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.70817858 |
| 86 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.69700844 |
| 87 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.69693768 |
| 88 | Endometrial cancer_Homo sapiens_hsa05213 | 0.69366663 |
| 89 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.68323564 |
| 90 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.67858001 |
| 91 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.66757767 |
| 92 | ABC transporters_Homo sapiens_hsa02010 | 0.66498517 |
| 93 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.65456721 |
| 94 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.64900444 |
| 95 | Focal adhesion_Homo sapiens_hsa04510 | 0.64590223 |
| 96 | Insulin resistance_Homo sapiens_hsa04931 | 0.63476604 |
| 97 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.63410438 |
| 98 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.62994391 |
| 99 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.61586205 |
| 100 | Hepatitis B_Homo sapiens_hsa05161 | 0.60758784 |
| 101 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.60260577 |
| 102 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.58617937 |
| 103 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.58004736 |
| 104 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.57782886 |
| 105 | Thyroid cancer_Homo sapiens_hsa05216 | 0.57428181 |
| 106 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.56953154 |
| 107 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.55854087 |
| 108 | Leishmaniasis_Homo sapiens_hsa05140 | 0.55788741 |
| 109 | Prion diseases_Homo sapiens_hsa05020 | 0.52066765 |
| 110 | Circadian rhythm_Homo sapiens_hsa04710 | 0.51425133 |
| 111 | Endocytosis_Homo sapiens_hsa04144 | 0.51138708 |
| 112 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.47505531 |
| 113 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.46860595 |
| 114 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.46351663 |
| 115 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.44723277 |
| 116 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.44691391 |
| 117 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.43848819 |
| 118 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.41148861 |
| 119 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.39034761 |
| 120 | Platelet activation_Homo sapiens_hsa04611 | 0.38942283 |
| 121 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.38423514 |
| 122 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38120051 |
| 123 | Lysine degradation_Homo sapiens_hsa00310 | 0.37503365 |
| 124 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.37320824 |
| 125 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.36293439 |
| 126 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.34806144 |
| 127 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.33910049 |
| 128 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.33830732 |

